Microorganism

Delivering 1,000x greater sensitivity than conventional assays, the iomics GFAP Detection Kit (Digital Immunochip Method) enables precise quantification of astrocyte activation directly from blood samples. It provides a superior, non-invasive diagnostic solution for differentiating Alzheimer’s Disease (AD) from other cognitive disorders and monitoring pathological progression through amyloid burden and neuronal loss.